BioMarin Pharmaceutical Inc. (BMRN) Q3 2026 earnings results
BioMarin Pharmaceutical Inc. (BMRN) reported Q3 2026 results on Nov 2, 2026, 4:07:11 PM ET: adjusted EPS $0.23 vs. -$0.11 expected (beat by $0.34); revenue $1.02B. Outlook: Updated full-year 2026 revenue guidance to $3,800 million to $3,900 million.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (adjusted, diluted) | $0.23 | -$0.11 | Beat by $0.34 |
| Revenue | $1.02B | — | — |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Nov 2, 2026, 4:07:11 PM ET. Nexqual published them 3 min 32 s after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 32.1% from $776.13M.
Stock reaction
The results came out after the market closed. BMRN closed at $55.66 on November 3, 2026, down 3.1% from its $57.44 close on November 2, 2026 before the results.
Questions and answers
Did BioMarin Pharmaceutical Inc. beat earnings expectations?
Yes. BioMarin Pharmaceutical Inc. reported adjusted EPS of $0.23 against an average analyst estimate of -$0.11 (beat by $0.34).
What were BioMarin Pharmaceutical Inc.'s Q3 2026 earnings and revenue?
adjusted diluted EPS of $0.23 and revenue of $1.02B. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 32.1% from $776.13M.
When did BioMarin Pharmaceutical Inc. report Q3 2026 earnings?
Nov 2, 2026, 4:07:11 PM ET, in an SEC 8-K filing (Item 2.02).
How did BMRN stock react to the earnings?
The results came out after the market closed. BMRN closed at $55.66 on November 3, 2026, down 3.1% from its $57.44 close on November 2, 2026 before the results.
What did BioMarin Pharmaceutical Inc. say about its outlook?
Updated full-year 2026 revenue guidance to $3,800 million to $3,900 million.
More on BMRN
BMRN stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 2, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 4, 2026 at 10:48 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 4, 2026 at 10:48 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt